BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 579034)

  • 21. Human lymphocyte antigens in Graves' disease: correlation with persistent course of disease.
    Baldini M; Pappalettera M; Lecchi L; Orsatti A; Meroni L; Tozzi R; Scalamogna M; Cantalamessa L
    Am J Med Sci; 1995 Jan; 309(1):43-8. PubMed ID: 7825652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HL-A antigens in Japanese Patients with Graves' disease.
    Grumet FC; Payne RO; Konishi J; Mori T; Kriss JP
    Tissue Antigens; 1975 Nov; 6(5):347-52. PubMed ID: 1243595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people.
    Huang SM; Wu TJ; Lee TD; Yang EK; Shaw CK; Yeh CC
    Tissue Antigens; 2003 Feb; 61(2):154-8. PubMed ID: 12694583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives.
    Mather BA; Roberts DF; Scanlon MF; Mukhtar ED; Davies TF; Smith BR; Hall R
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):155-63. PubMed ID: 6893172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease.
    Farid NR; Barnard JM; Marshall WH
    Tissue Antigens; 1976 Sep; 8(3):181-9. PubMed ID: 989647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HLA DRW3 and Graves' disease (author's transl)].
    Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
    Ann Endocrinol (Paris); 1980; 41(1):70-2. PubMed ID: 6893111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Symposium on major histocompatibility antigens (HLA) and diseases. Supplement: HLA system in Japanese patients with diabetes or Graves's disease].
    Kawa A
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1416-8. PubMed ID: 583284
    [No Abstract]   [Full Text] [Related]  

  • 28. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
    Lacka K; Kordel M; Gembicki M
    Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologically-related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement.
    Kusaka I; Nagasaka S; Fujibayashi K; Hayashi H; Kawakami A; Nakamura T; Rokkaku K; Saito T; Higashiyama M; Honda K; Ishikawa S; Saito T
    Endocr J; 1999 Dec; 46(6):747-54. PubMed ID: 10724349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of human leukocyte D locus related antigens in Graves' disease.
    Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
    J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Graves' disease. Predominance of the DRw3 antigen (author's transl)].
    Allanic H; Fauchet R; Lorcy Y; Heim J; Guéguen M; Leguerrier AM; Genetet B
    Nouv Presse Med; 1980 Jun; 9(26):1823-6. PubMed ID: 6893077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype.
    Allannic H; Fauchet R; Lorcy Y; Gueguen M; Le Guerrier AM; Genetet B
    J Clin Endocrinol Metab; 1983 Oct; 57(4):719-22. PubMed ID: 6688428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA and Graves' disease or diabetes mellitus in Japan.
    Sasazuki T; Kohno Y; Iwamoto I; Kosaka K; Okimoto K; Maruyama H; Ishiba S; Konishi J; Takeda Y; Naito S
    N Engl J Med; 1978 Mar; 298(11):630-1. PubMed ID: 75503
    [No Abstract]   [Full Text] [Related]  

  • 34. Differentiation of autoimmune ophthalmopathy from Graves' hyperthyroidism by analysis of genetic markers.
    Kendall-Taylor P; Stephenson A; Stratton A; Papiha SS; Perros P; Roberts DF
    Clin Endocrinol (Oxf); 1988 Jun; 28(6):601-10. PubMed ID: 3254259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graves' disease and HLA: clinical and epidemiologic associations.
    Farid NR; Stone E; Johnson G
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):535-44. PubMed ID: 6894412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the association of NIDDM in Japanese patients with hyperthyroid Graves' disease.
    Komiya I; Takasu N; Yamada T; Ohara N; Ootsuka H; Ota M; Fukushima H; Sekikawa A; Tominaga M; Sasaki H
    Horm Res; 1992; 38(5-6):264-8. PubMed ID: 1307749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the HLA system in Japanese patients with Graves' disease (author's transl)].
    Nakamura S
    Igaku Kenkyu; 1980 Feb; 50(2):111-28. PubMed ID: 6895437
    [No Abstract]   [Full Text] [Related]  

  • 38. HLA antigens in Graves' disease.
    Bech K; Lumholtz B; Nerup J; Thomsen M; Platz P; Ryder LP; Svejgaard A; Siersbaek-Nielsen K; Hansen JM; Larsen JH
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):510-6. PubMed ID: 72471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients.
    van der Gaag R; Wiersinga WM; Koornneef L; Mourits MP; Prummel MF; Berghout A; de Vries RR; Schreuder GM; D'Amaro J
    J Endocrinol Invest; 1990 Jun; 13(6):489-92. PubMed ID: 2258577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of HLA with Graves' disease in Chinese.
    Tong ZH; Zhu G; Yan LX; Zhu J; Feng YG; Xu G
    Chin Med J (Engl); 1987 Apr; 100(4):296-8. PubMed ID: 3115694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.